Basit öğe kaydını göster

dc.contributor.authorAltas, Omer Faruk
dc.contributor.authorKizilkaya, Mehmet
dc.date.accessioned2024-03-12T19:34:53Z
dc.date.available2024-03-12T19:34:53Z
dc.date.issued2021
dc.identifier.issn2149-2042
dc.identifier.issn2149-4606
dc.identifier.urihttps://doi.org/10.5222/MMJ.2021.64160
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/487166
dc.identifier.urihttps://hdl.handle.net/20.500.12450/2754
dc.description.abstractObjective: In this study, we aimed to reveal the level of predicting mortality of the Neutrophil/Lymphocyte (NLR) and Platelet/Lymphocyte Ratios (TLR) calculated in patients hospitalized with the diagnosis of pneumonia in the intensive care unit when compared with other prognostic scores.Method: The hospital records of 112 patients who were admitted to the intensive care unit between January 2015 and January 2018 and met the inclusion criteria were retrospectively reviewed. The patients' demographic data, the NLR and PLR levels, and the APACHE II (Acute Physiology and Chronic Health Evaluation II) and SOFA (Sequential Organ Failure Assessment) scores were calculated from the patient files.Results: Of the 112 patients examined, 70 were males. The risk analysis showed that the male gender had 2.7 times higher risk of mortality. The NLR, PLR, APACHE II, and SOFA values were found statistically significant in predicting mortality (p<0.001). An evaluation of the risk ratios demonstrated that each one point increase in the NLR increased the mortality risk by 5%, and each one point increase in the SOFA score increased the mortality risk by 13% (p<0.05). In the ROC (receiver operating characteristic) analysis, the NLR assessment proved to be the most powerful, most specific, and sensitive test. The cut-off values were 11.3 for the NLR, 227 for the PLR, 29.8 for the APACHE II scores, and 5.5 for the SOFA scores.Conclusion: We believe that NLR and PLR are strong and independent predictors of mortality that can be easily and cost-effectively tested.en_US
dc.language.isoengen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofMedeniyet Medical Journalen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMortalityen_US
dc.subjectneutrophil-to-lymphocyte ratioen_US
dc.subjectplatelet-to-lymphocyte ratioen_US
dc.subjectpneumoniaen_US
dc.subjectprognosisen_US
dc.titleThe Effects of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Prognostic Markers in Determining the Mortality in Patients Diagnosed With Pneumonia in Intensive Careen_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.identifier.volume36en_US
dc.identifier.issue2en_US
dc.identifier.startpage130en_US
dc.identifier.endpage137en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-85109292297en_US
dc.identifier.trdizinid487166en_US
dc.identifier.doi10.5222/MMJ.2021.64160
dc.department-temp[Altas, Omer Faruk] Izmir Bakircay Univ, Cigli Training & Res Hosp, Dept Anesthesiol & Reanimat, Izmir, Turkey; [Kizilkaya, Mehmet] Amasya Univ, Sabuncuoglu Serafettin Training & Res Hosp, Dept Anesthesiol & Reanimat, Amasya, Turkeyen_US
dc.identifier.wosWOS:001109453000001en_US
dc.identifier.pmid34239765en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster